Cargando…

Evaluating Deep Learning models for predicting ALK-5 inhibition

Computational methods have been widely used in drug design. The recent developments in machine learning techniques and the ever-growing chemical and biological databases are fertile ground for discoveries in this area. In this study, we evaluated the performance of Deep Learning models in comparison...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espinoza, Gabriel Z., Angelo, Rafaela M., Oliveira, Patricia R., Honorio, Kathia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842961/ https://www.ncbi.nlm.nih.gov/pubmed/33508008 http://dx.doi.org/10.1371/journal.pone.0246126

Ejemplares similares

Advances and Perspectives in Applying Deep Learning for Drug Design and Discovery
por: Lipinski, Celio F., et al.
Publicado: (2019)

Transfer and Multi-task Learning in QSAR Modeling: Advances and Challenges
por: Simões, Rodolfo S., et al.
Publicado: (2018)

Structure-Based Virtual Screening, Molecular Dynamics and Binding Free Energy Calculations of Hit Candidates as ALK-5 Inhibitors
por: Araujo, Sheila C., et al.
Publicado: (2020)

Studies on the Dual Activity of EGFR and HER-2 Inhibitors Using Structure-Based Drug Design Techniques
por: de Angelo, Rafaela Molina, et al.
Publicado: (2018)

The role of Alk-1 and Alk-5 in the mechanosensing of chondrocytes
por: Sanz-Ramos, Patricia, et al.
Publicado: (2014)

Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch
por: Aspalter, Irene Maria, et al.
Publicado: (2015)

Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on‐target ALK inhibitors in neuroblastoma
por: Tucker, Elizabeth R., et al.
Publicado: (2017)

Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma
por: Filipponi, Doria, et al.
Publicado: (2022)

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma
por: George, Bhawana, et al.
Publicado: (2019)

Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC
por: Xiao, Juanjuan, et al.
Publicado: (2022)

Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma
por: George, Bhawana, et al.
Publicado: (2023)

Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates
por: Serafim, Mateus S.M., et al.
Publicado: (2021)

Genomic and experimental evidence that ALK(ATI) does not predict single agent sensitivity to ALK inhibitors
por: Inam, Haider, et al.
Publicado: (2021)

Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition
por: Masood, Ashiq, et al.
Publicado: (2021)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

Marine Data Prediction: An Evaluation of Machine Learning, Deep Learning, and Statistical Predictive Models
por: Ali, Ahmed, et al.
Publicado: (2021)

Identification of Electronic and Structural Descriptors of Adenosine Analogues Related to Inhibition of Leishmanial Glyceraldehyde-3-Phosphate Dehydrogenase
por: Lozano, Norka B. H., et al.
Publicado: (2013)

Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment
por: Javanmardi, Niloufar, et al.
Publicado: (2019)

ALK5 deficiency inhibits macrophage inflammation and lipid loading by targeting KLF4
por: Li, Wenyan, et al.
Publicado: (2020)

Mechanisms of suppression of cell growth by dual inhibition of ALK and MEK in ALK-positive non-small cell lung cancer
por: Shrestha, N., et al.
Publicado: (2019)

PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK ‐rearranged lung cancer
por: Talwelkar, Sarang S., et al.
Publicado: (2023)

Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance
por: Okada, Koutaroh, et al.
Publicado: (2019)

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK
por: Damm-Welk, Christine, et al.
Publicado: (2016)

Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition
por: Kerner, Gerald S. M. A., et al.
Publicado: (2016)

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
por: Uruga, Hironori, et al.
Publicado: (2018)

Central nervous system involvement of systemic ALK-positive histiocytosis with KIF5B-ALK fusion
por: Aoki, Yuzuna, et al.
Publicado: (2022)

5G Traffic Prediction Based on Deep Learning
por: Gao, Zihang
Publicado: (2022)

Transcriptome analysis reveals key genes modulated by ALK5 inhibition in a bleomycin model of systemic sclerosis
por: Decato, Benjamin E, et al.
Publicado: (2021)

ALK inhibition activates LC3B-independent, protective autophagy in EML4-ALK positive lung cancer cells
por: Schläfli, Anna M., et al.
Publicado: (2021)

ALK and NSCLC: Targeted therapy with ALK inhibitors
por: Hallberg, Bengt, et al.
Publicado: (2011)

ALK Inhibitors in the Treatment of ALK Positive NSCLC
por: Khan, Muhammad, et al.
Publicado: (2019)

CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018)

Prognostic and predictive markers in glioblastoma and ALK overexpression
por: Kim, Jang-Hee
Publicado: (2021)

Molecular Features Related to HIV Integrase Inhibition Obtained from Structure- and Ligand-Based Approaches
por: de Carvalho, Luciana L., et al.
Publicado: (2014)

Pattern Recognition Techniques Applied to the Study of Leishmanial Glyceraldehyde-3-Phosphate Dehydrogenase Inhibition
por: Lozano, Norka B. H., et al.
Publicado: (2014)

Alk3/Alk3b and Smad5 Mediate BMP Signaling during Lymphatic Development in Zebrafish
por: Kim, Jun-Dae, et al.
Publicado: (2014)

Visual Field Prediction: Evaluating the Clinical Relevance of Deep Learning Models
por: Eslami, Mohammad, et al.
Publicado: (2022)

An automated framework for evaluation of deep learning models for splice site predictions
por: Zabardast, Amin, et al.
Publicado: (2023)

Evaluation of Deep Learning Architectures for Aqueous Solubility Prediction
por: Panapitiya, Gihan, et al.
Publicado: (2022)

5′ ALK Amplification in Neuroblastoma: A Case Report
por: Akhavanfard, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5l7k4sspbb0kd5ca5plkf6opb4